Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases

por Lee, Lucia, Samardzic, Kate, Wallach, Michael, Frumkin, Lyn R., Mochly-Rosen, Daria
Publicado 2021

COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play

por Frumkin, Lyn R, Lucas, Michaela, Wallach, Michael, Scribner, Curtis L, St John, Tom, Mochly-Rosen, Daria
Publicado 2022

Treatment-refractory ulcerative colitis responsive to indigo naturalis

por Saiki, Julie P, Andreasson, Johan OL, Grimes, Kevin V, Frumkin, Lyn R, Sanjines, Elvi, Davidson, Matthew G, Park, KT, Limketkai, Berkeley
Publicado 2021

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study

por Chua, Joel V., Ntem‐Mensah, Afua, Abutaleb, Ameer, Husson, Jennifer, Mutumbi, Lydiah, Lam, Ka Wing, Ghosh, Alip, Romani, Sara, Poonia, Bhawna, Lee, Sam, Luz Pascual, M., Frumkin, Lyn R., Kottilil, Shyamsundaran
Publicado 2020

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19

por Frumkin, Lyn R., Lucas, Michaela, Scribner, Curtis L., Ortega-Heinly, Nastassja, Rogers, Jayden, Yin, Gang, Hallam, Trevor J., Yam, Alice, Bedard, Kristin, Begley, Rebecca, Cohen, Courtney A., Badger, Catherine V., Abbasi, Shawn A., Dye, John M., McMillan, Brian, Wallach, Michael, Bricker, Traci L., Joshi, Astha, Boon, Adrianus C. M., Pokhrel, Suman, Kraemer, Benjamin R., Lee, Lucia, Kargotich, Stephen, Agochiya, Mahima, John, Tom St., Mochly-Rosen, Daria
Publicado 2022